研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

光生物调节 CME 第二部分:皮肤病学的临床应用。

Photobiomodulation CME part II: Clinical applications in dermatology.

发表日期:2024 Feb 01
作者: Jessica Mineroff, Jalal Maghfour, David M Ozog, Henry W Lim, Indermeet Kohli, Jared Jagdeo
来源: J Am Acad Dermatol

摘要:

光生物调节(PBM)是皮肤病学中一种新兴的治疗方式,随着办公室和家庭的使用越来越多。 PBM 是使用红光(620-700 nm)和近红外(700-1440 nm)光谱中的各种光源作为光疗法的一种形式。 PBM 通常通过低强度激光或发光二极管进行管理。研究表明,PBM 可有效治疗癌症治疗继发的病症、脱发、溃疡、单纯疱疹病毒、痤疮、皮肤再生、伤口和疤痕。与其他治疗相比,PBM 为患者带来了许多好处。它是无创的、经济有效的、对患者来说很方便,并且具有良好的安全性。 PBM 可用作其他治疗方式(包括药物治疗)的替代方案或辅助手段。对于皮肤科医生来说,重要的是要更好地了解办公室内 PBM 的临床知识,并建议患者正确使用家用设备,以便随着这项技术的发展,最好地管理安全性和期望。 PBM 波长可对不同皮肤类型、种族和民族产生不同的生物效应;因此,皮肤科医生为接受 PBM 治疗的有色皮肤患者提供适当的咨询也很重要。未来的临床试验对于针对不同状况和皮肤类型提出标准化建议是必要的。版权所有 © 2024。由 Elsevier Inc. 出版。
Photobiomodulation (PBM) is an emerging treatment modality in dermatology with increasing office and home-based use. PBM is the use of various light sources in the red light (620-700 nm) and near-infrared (700-1440 nm) spectrum as a form of light therapy. PBM is often administered through low-level lasers or light-emitting diodes. Studies show that PBM can be used effectively to treat conditions secondary to cancer therapies, alopecia, ulcers, herpes simplex virus, acne, skin rejuvenation, wounds, and scars. PBM offers patients many benefits compared to other treatments. It is noninvasive, cost-effective, convenient for patients, and offers a favorable safety profile. PBM can be used as an alternative or adjuvant to other treatment modalities including pharmacotherapy. It is important for dermatologists to gain a better clinical understanding of PBM for in-office administration and to counsel patients on proper application for home-use devices to best manage safety and expectations as this technology develops. PBM wavelengths can induce varied biological effects in diverse skin types, races, and ethnicities; therefore, it is also important for dermatologists to properly counsel their skin of color patients who undergo PBM treatments. Future clinical trials are necessary to produce standardized recommendations across conditions and skin types.Copyright © 2024. Published by Elsevier Inc.